CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TSH Biopharm Corporation Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TSH Biopharm Corporation Ltd
3F-1
No.3-1, Park Street, Nangang District
Phone: +886 226558525p:+886 226558525 TAIPEI, 115  Taiwan Ticker: 84328432
Business Summary
TSH Biopharm Corporation Ltd is a Taiwan-based company mainly engaged in the manufacturing and sales of pharmaceutical preparations. The Company mainly provides cardiovascular drugs, gastroenterology drugs, central nervous system drugs and precision medical testing, including Amtrel, Rytmonorm, Mopride, Aleviatin, Lonine, and others. The Company mainly sells its products in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board C.Lin 72 5/29/2020 5/29/2020
Chief Financial Officer RongliangGao 4/1/2024 4/1/2024
General Manager Sze-YuanYang 4/1/2024 1/17/2019
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 76 (As of 12/31/2020)
Outstanding Shares: 38,398,000 (As of 9/30/2024)
Shareholders: 3,356
Stock Exchange: TPO
Fax Number: +886 226558526


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024